Section Arrow
Quote
AXGN.NASDAQ
- Axogen
Quotes are at least 15-min delayed:2025/08/25 06:09 EDT
Pre Market
Last
 --
-- (--)
Bid
15.7
Ask
17.03
High -- 
Low -- 
Volume -- 
Regular Hours
Last
 16.26
+0.42 (+2.65%)
Day High 
16.45 
Prev. Close
15.84 
1-M High
15.92 
Volume 
1.00M 
Bid
15.7
Ask
17.03
Day Low
15.79 
Open
15.96 
1-M Low
11.61 
Market Cap 
728.84M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 14.89 
20-SMA 14.09 
50-SMA 12.26 
52-W High 21 
52-W Low 9.215 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.10/0.60
Enterprise Value
795.56M
Balance Sheet
Book Value Per Share
2.44
Cash Flow
Cash Flow Yield
0.01
Income Statement
Total Revenue
187.34M
Operating Revenue Per Share
3.31
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
NXLNexalin Technology1.02+0.29+39.73%-- 
Pre Market 0.95 -0.07 -6.86%
IINNInspira Technologies Oxy BHN Ltd1.17-0.08-6.40%-- 
Pre Market 1.2 +0.03 +2.56%
BSXBoston Scientific Corp106.17+0.96+0.91%62.63PE
Pre Market 106.17 0 0.00%
PACBPacific Biosciences of California1.38+0.12+9.52%-- 
Pre Market 1.37 -0.01 -0.72%
QSIQuantum-Si1.14+0.03+2.70%-- 
Pre Market 1.17 +0.03 +2.63%
Quotes are at least 15-min delayed：2025/08/25 06:09 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.